Business Context and Reporting Period
Company: Global Medical REIT Inc. (GMRE)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Business Overview: An internally managed REIT that acquires healthcare facilities (medical office buildings, inpatient rehab, etc.) and leases them to physician groups and healthcare systems. As of December 31, 2024, the portfolio consisted of 190 buildings with approximately 4.8 million leasable square feet and $110 million in annualized base rent.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Total Revenue | $138.8 million | $141.0 million |
| Net Income | $6.7 million | $21.7 million |
| Net Income Attributable to Common Stockholders | $0.8 million ($0.01/share) | $14.8 million ($0.23/share) |
| Funds From Operations (FFO) | $53.6 million ($0.75/share) | $58.4 million ($0.83/share) |
| Adjusted FFO (AFFO) | $63.4 million ($0.89/share) | $64.3 million ($0.91/share) |
| Operating Cash Flow | $70.0 million | $68.4 million |
| Total Debt (Net) | $646.1 million | $611.2 million |
| Weighted Average Interest Rate | 3.75% | 3.83% |
| Dividends Per Common Share | $0.84 | $0.84 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by $2.3 million (1.6%) primarily due to the full-year impact of property dispositions in 2023 and 2024, partially offset by a 15-property acquisition in 2024.
- Net Income Drop: Net income fell significantly by $15.0 million. Key drivers included a lower gain on sale of investment properties ($4.2 million in 2024 vs. $15.6 million in 2023) and a $1.7 million impairment charge on a facility in Derby, Kansas.
- Expense Increases: General and administrative expenses rose by $4.3 million, largely due to $3.2 million in severance costs related to the CEO transition and increased stock-based compensation.
- Portfolio Activity: Completed a 15-property acquisition ($80.3 million) and seven dispositions ($60.7 million gross proceeds). Two of the dispositions were sold to a new joint venture with Heitman.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
Management highlights an aging population and the shift to outpatient care as positive long-term trends. However, they note that elevated interest rates and inflationary pressures have constrained the ability to acquire assets meeting investment requirements. The company expects to rely on external capital sources (debt and equity) to fund future needs.
Unusual Items and Contingencies
- CEO Transition: On January 8, 2025, the company announced a transition agreement with CEO Jeffrey Busch, who will remain until a successor is appointed or June 30, 2025. A $3.2 million severance charge was accrued in 2024.
- Tenant Bankruptcies:
- Steward Health Care: Filed Chapter 11 in May 2024; rejected a lease at the Beaumont, Texas facility. The company has a $2.4 million claim (mix of priority and unsecured).
- Prospect Medical Group: Filed Chapter 11 on January 11, 2025. Owes approximately $2.4 million across three facilities. The company awaits a decision on lease acceptance or rejection.
- Impairment: Recognized a $1.7 million impairment loss in Q4 2024 for the Derby, Kansas facility, which was sold in February 2025.
Key Risks
- Interest Rate Risk: Interest rate swaps on the $350 million Term Loan A expire in April 2026. Refinancing or renewing these hedges may occur at significantly higher rates (current 5-year forward SOFR swap rate is ~3.97% vs. current hedge rate of 1.36%).
- Tenant Concentration: Top three tenants (LifePoint Health, Encompass Health, Memorial Health) represent 19.3% of annualized base rent.
- Geographic Concentration: Significant exposure to Texas (16.2% of ABR), Florida (11.9%), and Ohio (8.8%).
Investor Verification Checklist
- Debt Refinancing Costs: Verify the impact of the April 2026 Term Loan A swap expiration on future interest expenses and AFFO.
- Tenant Bankruptcy Recovery: Monitor the resolution of the Steward Health Care and Prospect Medical Group bankruptcies to assess potential losses on the $4.8 million in combined receivables.
- CEO Succession: Confirm the timeline and terms of the new CEO appointment and any additional compensation costs.
- Acquisition Pipeline: Review the status of the remaining two properties in the five-property portfolio under contract ($38.1 million) and the likelihood of closing in Q2 2025.
- Dividend Coverage: Assess the sustainability of the $0.84 annual dividend given the decline in Net Income and the pressure on FFO from interest rate resets.